Natural Health Trends Corp income statement
In fiscal 2025, Natural Health Trends Corp reported revenue of $39.8m, down 7.4% on the year before, operating income of −$1.8m (a -4.5% margin) and net income of −$882,000, or −$0.08 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24 | 31 | 38 | 53 | 125 | 265 | 288 | 198 | 192 | 78 | 62 | 60 | 49 | 44 | 43 | 40 | 34 |
| Cost of revenue | — | — | — | — | — | — | — | 39 | 39 | 20 | 17 | 15 | 13 | 11 | 11 | 11 | 9 |
| Gross profit | 17 | 23 | 28 | 40 | 98 | 211 | 233 | 159 | 153 | 58 | 45 | 45 | 36 | 33 | 32 | 29 | 25 |
| Selling, general and administrative | 10 | 9 | 9 | 12 | 20 | 36 | 43 | 32 | 31 | 27 | 18 | 18 | 16 | 16 | 16 | 15 | 14 |
| Operating income | −3 | 2 | 3 | 4 | 21 | 48 | 64 | 43 | 34 | −7 | 1 | 2 | −0 | −2 | −1 | −2 | −2 |
| Interest expense | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Income before tax | — | — | 3 | 4 | 21 | 48 | 64 | 43 | 35 | −6 | 1 | 2 | 1 | 1 | 1 | −1 | −1 |
| Income tax | −0 | −0 | −0 | 0 | 0 | 1 | 9 | 20 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −2 | 2 | 3 | 4 | 20 | 47 | 55 | 24 | 31 | −6 | 1 | 1 | 0 | 1 | 1 | −1 | −1 |
| Diluted EPS | −$0.23 | $0.21 | $0.23 | $0.36 | $1.61 | $3.82 | $4.83 | $2.09 | $2.74 | −$0.52 | $0.07 | $0.09 | $0.03 | $0.05 | $0.05 | −$0.08 | −$0.15 |
| Diluted shares (average) | 11m | 11m | 11m | 11m | 13m | 12m | 11m | 11m | 11m | 11m | 11m | 11m | 11m | 11m | 11m | 11m | 10m |
| EBITDA | −2 | 2 | 3 | 4 | 21 | 48 | 65 | 44 | 34 | −7 | 1 | 2 | −0 | −2 | −1 | −2 | −2 |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11 | 11 | 10 | 9 | 10 | 9 | 8 | 8 |
| Cost of revenue | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 2 |
| Gross profit | 8 | 8 | 7 | 7 | 7 | 7 | 6 | 6 |
| Selling, general and administrative | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 |
| Operating income | −0 | −0 | −0 | −0 | −1 | −0 | −1 | −0 |
| Income before tax | −0 | 0 | 0 | −0 | −0 | −0 | −0 | −0 |
| Income tax | −0 | −0 | 0 | 0 | 0 | −0 | −0 | 0 |
| Net income | 0 | 0 | 0 | −0 | −1 | −0 | −0 | −0 |
| Diluted EPS | $0.02 | $0.01 | $0.00 | −$0.04 | −$0.05 | −$0.02 | −$0.05 | −$0.03 |
| EBITDA | −0 | −0 | −0 | −0 | −1 | −0 | −1 | −0 |
Compare with peers
- Fitlife Brands, Inc. income statement
- Axil Brands, Inc. income statement
- Cbdmd, Inc. income statement
- United Guardian Inc income statement
- Mannatech Inc income statement
Head to head: FTLF vs NHTCAXIL vs NHTCNHTC vs YCBDNHTC vs UG
More: Personal Care Products stocks compared, Consumer Staples sector, rankings of US companies